It may be a Friday, but it’s not a slow news day by any means. There’s plenty of stock market and macroeconomic news that investors will want to catch up on as they head into the final half of the last day of trading this week.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
- Booz Allen (BAH) stock plummeted on a lackluster earnings report.
- President Donald Trump threatened Apple (AAPL) with a 25% tariff if iPhones aren’t made in America.
- The President also threatened the European Union (EU) with 50% tariffs.
- Nuclear energy stocks Oklo (OKLO) , Uranium Energy (UEC), and NuScale Power (SMR) surged on reports of incoming executive orders to increase nuclear power.
- Imunon (IMNN) stock rallied on strong clinical trial results.
- Deckers (DECK) stock dove on dismal guidance.
- Analysts weighed in on Nvidia (NVDA) stock ahead of its earnings report next week.
- Bicara Therapeutics (BCAX) stock took a beating on clinical trial data.
- Hinge Health (HNGE) stock soared on its New York Stock Exchange debut.
- Meta Platforms (META) stock slipped despite an artificial intelligence (AI) win in Germany.
- Mercedes-Benz (DE:MBG) announced plans to open a North American headquarters in Atlanta, Georgia.
- Cryptocurrency exchange Kraken revealed plans to list tokenized versions of Nvidia, Apple, and Tesla (TSLA) shares.
- Merus (MRUS) stock rocketed in clinical data from a potential “best-in-class” cancer treatment.
- Texas passed a bill to create a strategic Bitcoin (BTC) reserve.
- Ross Stores (ROST) stock was slammed after the company withdrew its 2025 outlook.
- Gold ETFs rallied today on President Trump’s tariff threats.
- France said it’s ready to hit the U.S. with retaliatory tariffs.
- Wedbush analysts reiterated an Outperform rating and $140 price target for Palantir Technologies (PLTR) stock.
- Analog Devices (ADI) stock slipped on updated analyst coverage after its recent earnings report.
- Australia approved Eli Lilly’s (LLY) Kisunla Alzheimer’s medication.
- Wedbush said American-made iPhones are a “fairy tale.”
Keep up with all of the latest stock market news at TipRanks.